WHO ICTRP trial
Phase II study of stereotactic radiotherapy for kidney cancer using an MR-Linac…
JPRN-UMIN000045721 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-UMIN000045721 |
|---|---|
| Public title | Phase II study of stereotactic radiotherapy for kidney cancer using an MR-Linac system |
| Scientific title | Phase II study of stereotactic radiotherapy for kidney cancer using an MR-Linac system - MR-Linac based stereotactic radiotherapy for kidney cancer |
| Primary sponsor | Tohoku University |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase II |
| Countries | Japan |
| Conditions | Kidney cancer(primary kidney cancer) |
| Interventions | MR-Linac based stereotactic radiotherapy |
| Registration date | Oct 29, 2021 |
| Target size | 25 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: